Company Profile Senior Management Team Board of Directors Scientific Advisory Board Vision

Overview Protein Misfolding & Disease Pharmacological Chaperones Proposed Mechanism of Action

Overview AT1001 AT2101 AT2220

AT1001 AT2101 AT2220

Senior Management Team Corporate Governance Press Releases Events & Presentations SEC Filings Stock Performance Investor FAQs Contact Us

Overview Career Opportunities Benefits Working at Amicus

AT1001 AT2101 AT2220

AT2220 Clinical Trials

Amicus is currently conducting a Phase 1 clinical trial to assess the effects of AT2220 in healthy volunteers.